City of Hope Medical Group seeks a full-time academic Molecular Genomic Pathologist at the Assistant/Associate level to join their growing team in Duarte, CA. The successful candidate will serve as a faculty clinician in the Division of Molecular Pathology and Therapy Biomarkers, contributing to clinical care, education, and translational research within a nationally recognized cancer institute. This role involves interpreting molecular and genomic results, collaborating with a diverse team of professionals, and advancing precision oncology initiatives.
Practice Info
Located at Rivergrade within the Molecular Pathology, Genomics, and Cytogenomics CLIA Laboratory in Duarte, CA.
High-volume, state-of-the-art program performing more than 39,000 moderate to high complexity molecular tests annually across solid tumors and hematologic malignancies.
Testing portfolio centered on next-generation sequencing (NGS) and complemented by advanced molecular methodologies, including Sanger sequencing, real-time PCR and related technologies, fragment analysis, and MLPA.
Laboratory supports a diverse menu of testing including single-gene assays, large NGS panels, quantitative molecular assays, and emerging technologies in plasma-based cancer testing, measurable molecular residual disease (MMRD), and homologous recombination deficiency (HRD) assessment.
Responsibilities:
Serve as a faculty clinician in the Division of Molecular Pathology and Therapy Biomarkers with primary clinical, educational, and scholarly responsibilities in the Clinical Molecular Diagnostics Laboratory (CMDL).
Interpret and report molecular and genomics results in correlation with hematopathology assay results, surgical pathology relevant biomarker analysis, and in bone marrow transplant setting with HLA results.
Participate actively in assay development, validation, laboratory-developed testing, quality management initiatives, molecular tumor boards, proficiency testing, translational research, and clinical trials.
Contribute to scholarly productivity through publications, grant development, collaborative research, and national professional activities.
Represent the Clinical Laboratories on test utilization, departmental quality initiatives, Molecular Genomic Pathology diagnostic strategy, laboratory information systems committees, and other institutional activities.
Provide coverage and on-call support for other pathology services.
Provide a limited effort allocation for diagnostic sign-out in surgical pathology or hematopathology, based on the candidate's training, board certification, and departmental needs.
Collaborate with laboratory directors and clinical leaders across the City of Hope enterprise to promote excellence in clinical laboratory operations, research, education, and patient-centered care.
Compensation
Base Salary Range:
$310k to $480k for full-time employment (does not include incentive compensation or benefits).
Actual compensation will be adjusted for experience, training, hospital/community need and other factors.
Benefits:
Excellent benefits package, including a generous retirement contribution plan.
Relocation assistance may be available.
Shift & Schedule
Full-time employment.
Qualifications:
Medical Doctor (MD) or Doctor of Osteopathic Medicine (DO) degree.
Board eligible or board certified in Molecular Genetic Pathology (MGP) or Molecular Genomic Pathology.
Board certified in Anatomic Pathology and/or Clinical Pathology (AP/CP preferred) through the American Board of Pathology.
Eligible for unrestricted medical licensure in the State of California.
A minimum of two (2) years of experience working in or directing a clinical Molecular Genomic Pathology laboratory is preferred.
Board certified in Molecular Genetic Pathology (MGP) by the American Board of Pathology is preferred.
Additional fellowship training and/or board certification in Hematopathology, Cytogenetics, Clinical Informatics, or related disciplines is desirable.
More than two (2) years of faculty experience in an academic molecular pathology program is preferred.
Experience with translational research, Institutional Review Board (IRB) protocols, grant-supported research, and advanced molecular genomics methodologies is preferred.
Demonstrated ability to develop strategic plans for program growth, test utilization, laboratory integration, and expansion of molecular diagnostic services is preferred.
